Search research articles
Contact Us
Filters
Showing results (331-340 of 372) with videos related to
Page
of 38
Sort By:
AIDS Research and Human Retroviruses
|
October 6, 2012
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120
Nicos Karasavvas, Erik Billings, Mangala Rao, et al.
The Lancet. Respiratory Medicine
|
September 16, 2023
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Science (New York, N.Y.)
|
April 6, 2013
Influence of HLA-C expression level on HIV control
Richard Apps, Ying Qi, Jonathan M Carlson, et al.
Vaccines
|
October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection
Agnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Eclinicalmedicine
|
August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
Guy de Bruyn, Joyce Wang, Annie Purvis, et al.
Virus Evolution
|
June 24, 2026
Genomic epidemiology and evolutionary analysis of Lassa virus from small mammals suggest bidirectional viral movement across humans and animals
Anise N Happi, Olusola A Ogunsanya, Ayotunde E Sijuwola, et al.
The Journal of Infectious Diseases
|
April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Cell Reports. Medicine
|
April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
Jingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Plos Computational Biology
|
February 4, 2015
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial
Paul T Edlefsen, Morgane Rolland, Tomer Hertz, et al.
Page
of 38
Search research articles
Search
Showing results (331-340 of 372) with videos related to
Sort By:
Page
of 38
AIDS Research and Human Retroviruses
|
October 6, 2012
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120
Nicos Karasavvas, Erik Billings, Mangala Rao, et al.
The Lancet. Respiratory Medicine
|
September 16, 2023
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
Gustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Science (New York, N.Y.)
|
April 6, 2013
Influence of HLA-C expression level on HIV control
Richard Apps, Ying Qi, Jonathan M Carlson, et al.
Vaccines
|
October 28, 2025
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection
Agnes Hajduczki, William C Chang, Rafael De La Barrera, et al.
Eclinicalmedicine
|
August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study
Guy de Bruyn, Joyce Wang, Annie Purvis, et al.
Virus Evolution
|
June 24, 2026
Genomic epidemiology and evolutionary analysis of Lassa virus from small mammals suggest bidirectional viral movement across humans and animals
Anise N Happi, Olusola A Ogunsanya, Ayotunde E Sijuwola, et al.
The Journal of Infectious Diseases
|
April 19, 2018
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R Baden, Stephen R Walsh, Michael S Seaman, et al.
Cell Reports. Medicine
|
April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
Jingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Plos Computational Biology
|
February 4, 2015
Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial
Paul T Edlefsen, Morgane Rolland, Tomer Hertz, et al.
Page
of 38